HomeCompareNHNKY vs EQR

NHNKY vs EQR: Dividend Comparison 2026

NHNKY yields 2.21% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NHNKY wins by $1.52M in total portfolio value· pulled ahead in Year 4
10 years
NHNKY
NHNKY
● Live price
2.21%
Share price
$9.50
Annual div
$0.21
5Y div CAGR
73.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.57M
Annual income
$1,146,133.31
Full NHNKY calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — NHNKY vs EQR

📍 NHNKY pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHNKYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHNKY + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHNKY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHNKY
Annual income on $10K today (after 15% tax)
$187.89/yr
After 10yr DRIP, annual income (after tax)
$974,213.31/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, NHNKY beats the other by $969,559.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHNKY + EQR for your $10,000?

NHNKY: 50%EQR: 50%
100% EQR50/50100% NHNKY
Portfolio after 10yr
$808.1K
Annual income
$575,804.46/yr
Blended yield
71.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

NHNKY
No analyst data
Altman Z
6.6
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHNKY buys
0
EQR buys
0
No recent congressional trades found for NHNKY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHNKYEQR
Forward yield2.21%5.87%
Annual dividend / share$0.21$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR73.1%15.8%
Portfolio after 10y$1.57M$47.8K
Annual income after 10y$1,146,133.31$5,475.61
Total dividends collected$1.51M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NHNKY vs EQR ($10,000, DRIP)

YearNHNKY PortfolioNHNKY Income/yrEQR PortfolioEQR Income/yrGap
1$11,083$382.64$11,380$679.82$297.00EQR
2$12,544$686.04$13,014$837.25$470.00EQR
3$14,679$1,256.24$14,961$1,036.20$282.00EQR
4← crossover$18,084$2,378.06$17,297$1,289.22+$787.00NHNKY
5$24,090$4,739.69$20,121$1,613.15+$4.0KNHNKY
6$35,990$10,214.00$23,561$2,030.84+$12.4KNHNKY
7$63,196$24,686.41$27,783$2,573.54+$35.4KNHNKY
8$137,745$70,125.44$33,013$3,284.39+$104.7KNHNKY
9$394,660$247,272.33$39,547$4,223.51+$355.1KNHNKY
10$1,568,419$1,146,133.31$47,791$5,475.61+$1.52MNHNKY

NHNKY vs EQR: Complete Analysis 2026

NHNKYStock

Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.

Full NHNKY Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this NHNKY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHNKY vs SCHDNHNKY vs JEPINHNKY vs ONHNKY vs KONHNKY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.